Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Inequalities In Access to Treatment for Multiple Sclerosis In England Continue Despite Service Improvement Initiatives And Policy Reforms.
The representation of inflammatory signals in the brain - a model for subjective fatigue in multiple sclerosis.
Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.
Chronic inflammatory demyelinating polyneuropathy in children: a report of four patients with variable relapsing courses.
[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs].
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.
ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile.
Recognizing and overcoming potential barriers to oral medications for MS.
Erratum to: Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
A case-control study of dietary salt intake in pediatric-onset multiple sclerosis.
Neuronal autoantibodies in patients with Rasmussen's encephalitis.
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Yes.]
Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial.
Anti-Inflammatory Effects of Progesterone in Lipopolysaccharide-Stimulated BV-2 Microglia.
Acute-onset multifocal motor neuropathy (AMMN):how we meet the diagnosis.
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis.
Osteopontin in Immune-mediated Diseases.
Prevalence of neuropathic pain in early multiple sclerosis.
Myelinated mouse nerves studied by X-ray phase contrast zoom tomography.
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease.
A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain.
The Lin28/let-7 axis is critical for myelination in the peripheral nervous system.
[The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
Pages
« first
‹ previous
…
594
595
596
597
598
599
600
601
602
…
next ›
last »